Masako Oka

Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-β signaling

Mitsunobu R. Kano, Younsoo Bae, Caname Iwata et al. · Proceedings of the National Academy of Sciences · 2007 · 406 citations · Full text

Tgf-beta Inhibitors, Engineering, Biomedical Engineering +20

Inhibition of endogenous TGF-β signaling enhances lymphangiogenesis

Masako Oka, Caname Iwata, Hiroshi Suzuki et al. · Blood · 2008 · 217 citations · Full text

Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation

Sophia Bornstein, Ruth A. White, Stephen P. Malkoski et al. · Journal of Clinical Investigation · 2009 · 217 citations · Full text

USAG-1: a bone morphogenetic protein antagonist abundantly expressed in the kidney

Motoko Yanagita, Masako Oka, Tetsuro Watabe et al. · Biochemical and Biophysical Research Communications · 2004 · 144 citations

Urology, Sclerostin, Bone Morphogenic Protein +7

Inhibition of Cyclooxygenase-2 Suppresses Lymph Node Metastasis via Reduction of Lymphangiogenesis

Caname Iwata, Mitsunobu R. Kano, Akiyoshi Komuro et al. · Cancer Research · 2007 · 123 citations